Author:
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1791 | 1339 | 75 |
| Full Text Views | 11 | 2 | 0 |
| PDF Downloads | 9 | 1 | 0 |
Mebendazole in the Treatment of Dracontiasis
Oladele O. Kale
Oladele O. Kale
Department of Preventive and Social Medicine, University of Ibadan, Ibadan, Nigeria
Search for other papers by Oladele O. Kale in
Current site
Google Scholar
PubMed
Search for other papers by Oladele O. Kale in
Current site
Google Scholar
PubMed
In a controlled field trial of treatment for dracontiasis, mebendazole (Vermox®) was found to be effective in eliminating the adult worm and preventing clinical relapses, but it did not achieve significant amelioration of symptoms, subsidence of inflammation, or healing of ulcers. The failure is attributed to poor absorption and lack of anti-inflammatory action of the drug. Mebendazole was well tolerated and although two patients reported mild gastro-intestinal disturbances, which may be attributed to the drug, the study confirms that mebendazole is one of the safest anthelmintics in current use and is in that respect ideal for mass therapy.
Author Notes
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1791 | 1339 | 75 |
| Full Text Views | 11 | 2 | 0 |
| PDF Downloads | 9 | 1 | 0 |